Form 8-K - Current report:
SEC Accession No. 0000950170-22-002622
Filing Date
2022-03-02
Accepted
2022-03-02 09:00:56
Documents
14
Period of Report
2022-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eq-20220224.htm   iXBRL 8-K 64296
2 EX-99.1 eq-ex99_1.htm EX-99.1 19145
3 GRAPHIC img162018617_0.jpg GRAPHIC 200272
  Complete submission text file 0000950170-22-002622.txt   488625

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eq-20220224_pre.xml EX-101.PRE 11485
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eq-20220224.xsd EX-101.SCH 2484
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eq-20220224_lab.xml EX-101.LAB 14811
8 EXTRACTED XBRL INSTANCE DOCUMENT eq-20220224_htm.xml XML 4882
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 22701513
SIC: 2834 Pharmaceutical Preparations